MASCC Antiemetic Consensus Recommendations
MASCC shared a paper Snezana M. Bosnjak and colleagues authored on LinkedIn:
“Just published! MASCC Antiemetic Consensus Recommendations: Resource-Limited Settings.
Prevention of chemotherapy-induced nausea and vomiting (CINV) remains an essential supportive care need for patients receiving cancer treatment. Due to inadequate access to antiemetics in many countries, guideline-recommended CINV prophylaxis is not always possible. This paper formulates antiemetic recommendations for resource-limited settings and defines alternative antiemetic regimens for the CINV prophylaxis after highly and moderately emetic chemotherapy, when NK1-receptor antagonists are not accessible.
Read more in Supportive Care in Cancer.
Congratulations to the authors: Snezana M Bosnjak, Ana Zilic, Venkatraman Radhakrishnan, Vikas Ostwal, Matti Aapro, Hirotoshi Iihara, Teresa Smit and Richard Gralla.”
MASCC antiemetic consensus recommendations: resource-limited settings
Authors: Snezana M. Bosnjak et al.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023